RegASK
AI-Driven Regulatory Intelligence for Life Sciences and CPG Excellence.
Est 2018|Valuation $24.5M|Raised $21.9M
Published Sep 2, 2026
| Starting Price | Not public (custom quote; annual subscription; hybrid by coverage) | Free tier available; professional tier at a published per-user monthly rate (higher-end) | Not public (quote-based membership pricing) |
| Best For | Life Sciences + CPG teams needing regulatory workflow tools with AI assistance and an expert network (vendor positioning) | Teams needing regulatory change management and a searchable law library (strong US coverage) | Enterprises needing EHS/regulatory content and services for compliance programs |
| Key Strength | Vertical regulatory workflows and access to an expert network (vendor-stated strengths) | Published pricing for some tiers; productized assistant and law library | Established content/services footprint for enterprise EHS/regulatory programs |
| Key Weakness | Limited public third-party reviews; pricing not transparent; default no free pilot | Per-user pricing can be expensive; industry/coverage focus may differ | Quote-only pricing; may be oriented to EHS rather than RA workflow automation |
—
RegASK vs Regology:
RegASK vs Enhesa:
RegASK vs Compliance.ai / Ascent (financial regtech):